Discount Vitamins & Herbs

   
- Products by Category
- Alphabetic Product Listing

Home Go Shopping Specials Product Info Health News FAQs About Us Links Site Map

Hyaluronic Acid Center, Neptune Krill Oil & Rejuvenation Science for Doctors

Friday, August 31, 2007

Flaxseed Shows Potential to Reduce Hot Flashes

Data from a new Mayo Clinic study suggest that dietary therapy using flaxseed can decrease hot flashes in postmenopausal women who do not take estrogen.

“Hot flashes are a bothersome issue for women experiencing menopause,” says Sandhya Pruthi, M.D., Mayo Clinic breast health specialist and the study’s primary investigator. “We hope to find more effective nonhormonal options to assist women, and flaxseed looks promising.”

Participants were asked questions that the researchers translated into a hot flash score -- a combined measure of frequency and severity. The frequency of hot flashes decreased 50 percent over six weeks, and the overall hot flash score decreased an average 57 percent for the women who completed the trial.

Read details of this flaxseed hot flashes study.

Tuesday, August 28, 2007

Vitamin D3 Could Prevent 600,000 Cancer Cases Annually

A new study looked at the relationship between vitamin D serum levels and the risk of colon and breast cancer. Researchers have estimated 600,000 cases of cancer could be prevented each year if vitamin D3 levels met the target proposed by researchers.

“For the first time, we are saying that 600,000 cases of breast and colorectal cancer could be prevented each year worldwide, including nearly 150,000 in the United States alone.”

“This could be best achieved with a combination of diet, supplements and short intervals – 10 or 15 minutes a day – in the sun,” said Garland. It could be less for very fair-skinned individuals. He went on to say that “the appropriate dose of vitamin D in order to reach this level, could be very little in a lifeguard in Southern California… or quite a lot for someone in Northern Europe who tends to remain indoors most of the year.”

View more data on how Vitamin D3 could prevent 600 deaths annually.

Monday, August 27, 2007

Mitochondrial Dysfunction Associated With Alzheimer's Disease

Researchers have provided new information about how communication among neurons may be prevented from deteriorating in conditions such as Alzheimer’s disease.

Deterioration of synapses and axons can be delayed thanks to a protein created by a gene called the slow Wallerian degeneration (Wlds) gene.

These results reveal for the first time that mitochondria are involved in the protection of neurons provided by the Wlds gene and suggest that targeting some of the proteins identified in this study may lead to novel therapies for the treatment of AD, motor neuron diseases, and prion diseases.

Read details of this Alzheimer's Disease mitochondrial dysfunction study.

Sunday, August 26, 2007

Omega-3's Provide Relief for Some MS Patients

New findings confirm previous research findings that suggest the intake of fish oil, containing Omega-3 fatty acids could provide a measure of relief for those with Multiple Sclerosis, a disease that is progressive, debilitating, and without a cure.

The researchers found there was a 58 percent decrease in MMP-9 levels secreted from immune cells of MS volunteers after three months of fish oil supplementation compared to baseline levels.

According to Dr. Shinto, the lead researcher, “These findings confirm previous research findings that suggest the intake of fish oil, containing Omega-3 fatty acids could provide a measure of relief for those with MS, a disease that is progressive, debilitating, and without a cure.” In lieu of eating fish, Omega-3 supplements from Neptune Krill Oil provide a healthy, contaminant-free source of DHA and EPA.

Read more details on this omega-3 multiple sclerosis study.

Friday, August 24, 2007

Probiotics Ease Constipation

The probiotic Lactobacillus casei rhamnosu (Lcr35) was effective in treating children with chronic constipation.

Researchers found patients who received Magnesium or probiotics had a higher defecation frequency, higher percentage of treatment success, less use of glycerin enema and less hard stool than the placebo group. There was no significant difference between MgO and probiotic groups in the previously mentioned comparisons.

No adverse effect was noted in probiotic and placebo groups. Only one patient in the MgO group suffered from mild diarrhea. Researchers concluded probiotics were effective in treating children with chronic constipation.

Read details of this probiotics constipation study.

Tuesday, August 21, 2007

Omega-3 Fatty Acids May Prevent Retinopathy-Related Blindness

Harvard researchers report a study in mice found greater intake of long-chain omega-3 essential fatty acids (EFAs) protected against blindness attributed to abnormal ocular blood vessel growth.

Mice on the omega-3 diet had an area with vessel loss 40- to 50-percent smaller than that of mice on the omega-6 diet, significantly decreasing pathological vessel growth and aiding normal vessel re-growth. Researchers further reported a 2-percent change in omega-3 intake was sufficient to decrease disease severity by 50 percent.

In lieu of eating fish, Omega-3 supplements from Neptune Krill Oil provide a healthy, contaminant-free source of DHA and EPA.

Read details of this omega-3 fatty acid retinopathy-related blindness study.

Monday, August 20, 2007

Drugs to Raise HDL “Good” Cholesterol May Be Dangerous

With 40 percent of all heart attacks and related cardiovascular problems occurring in people who have low levels of so-called “good” cholesterol, researchers have long sought medications to increase the amount of this type of cholesterol in the body’s circulation.

But a new review of 31 randomized controlled trials published in the Journal of the American Medical Association suggests that so far, only modest evidence supports the use of most medications to raise levels of high-density lipoprotein (HDL) — good cholesterol. Some are even harmful.

Fortunately, lifestyle changes can help without negative side effects, according to the review. “The safest way to raise HDL is by weight loss, exercise and smoking cessation.” Raising HDL by eating fish or taking fish oil to increase intake of omega-3 fatty acids is another effective strategy, the review suggested. In lieu of eating fish, Omega-3 supplements from Neptune Krill Oil provide a healthy, contaminant-free source of DHA and EPA, shown to increase HDL by 45%.

Read how HDL Cholesterol May Be Enhanced by Neptune Krill Oil, but not drugs.

Sunday, August 19, 2007

Increased Folate May Reduce Breast Cancer Risk

An increased consumption of folate may reduce the risk of breast cancer by 44 percent, says a new study from Sweden.

After 9.5 years of follow-up, 392 cases of breast cancer had been diagnosed. The average folate intake for the women was 238 micrograms per day, and 19 percent of subjects used folic acid supplements.

The researchers calculated that women in the highest average intake group (456 micrograms of folate per day) had a 44 percent lower risk of invasive breast cancer than women in the lowest average intake group (160 micrograms of folate per day).

Read details on this folic acid breast cancer risk reduction study.

Thursday, August 16, 2007

Green Tea Stops Colon Cancer

Green tea stops the growth of colon tumors in their infancy, says a new study using mice, but merely drinking green tea offers no benefits against larger tumors.

Green tea contains between 30 and 40 percent of water-extractable polyphenols, while black tea (green tea that has been oxidized by fermentation) contains between 3 and 10 percent. The four primary polyphenols found in fresh tealeaves are epigallocatechin gallate (EGCG), epigallocatechin, epicatechin gallate, and epicatechin.

A large body of epidemiological data already indicates that the beverage and its extracts may offer significant benefits for lowering the risk of colon cancer.

Read details on this green tea colon cancer study.

Wednesday, August 15, 2007

Cases of Jaw Bone Death Caused by Fosamax Often Unreported

Merck, maker of osteoporosis drug Fosamax, may have “seriously under reported” the risks of "jawbone death" related to the drug, according to the American Association of Oral and Maxillofacial Surgeons.

"Jawbone death" is associated with the use of a bisphosphonate class of drugs (to which Fosamax belongs). Also known as Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ), is a serious side effect that destroys the bone in the jaw, and is difficult to treat.

The article does not mention that taking daily calcium and vitamin D-3 supplements is required with the drugs.

View details on this Fosamax jaw bone death reporting study.

Monday, August 13, 2007

Staggering Cost of End-Stage Renal Disease

Recent progress in the prevention and treatment of end-stage renal disease (ESRD) in the United States give reason for "cautious optimism," but skyrocketing costs are a major concern.

In 2004, the most recent year for which complete data were available, 104,364 Americans (approximately 0.03 percent of the population) started dialysis or received a kidney transplant. Most important, the probabilities of survival for U.S. ESRD patients have improved steadily since the late 1980s—especially remarkable since today's dialysis patients are older and sicker than the dialysis population of 20 years ago.

With the continued growth of the ESRD population, costs grew by 57 percent between 1999 and 2004. "The cost implications are staggering," Dr. Foley adds. "The most recent estimates showed that Medicare costs for ESRD reached $20.1 billion, while non-Medicare costs rose to $12.4 billion." Costs for the care of ESRD patients now account for 6.7 percent of total Medicare expenditures.

And yet, in another article, 81% Positive Response to Coenzyme Q10 Treatment for Chronic Kidney Failure. But this CoQ10 therapy would only cost $100 per month and put a lot of kidney dialysis technicians out of business.

Read details about this ESRD End-Stage Renal Disease cost study.

Saturday, August 11, 2007

Insulin Resistance Associated With CVD, Cancer, Diabetes and Alzheimer’s

New and important evidence shows that Insulin Resistance Syndrome can lead to elevated risk for cardiovascular disease, breathing and sleep disorders, liver disease, Polycystic Ovarian Syndrome, type 2 diabetes, certain cancers, Alzheimer’s Disease and more.

USDA studies show cinnamon promotes glucose metabolism and supports healthy cholesterol levels in individuals with type 2 diabetes.

Congress will also address the many manifestations of insulin resistance – heart disease, diabetes, fatty liver disease, sleep & breathing disorders, cancer, polycystic ovarian syndrome and certain brain disorders like Alzheimer’s Disease. “This metabolic disorder underlies some of the deadliest and most costly diseases in the U.S. An early intervention for prevention is critical” Said Dr. Yehuda Handelsman of the Metabolic Institute of America

Read about insulin resistance and CVD, cancer, diabetes and Alzheimer's.

Friday, August 10, 2007

Osteoporosis Drugs Don't Work Without Hi-Dose Calcium and Vitamin D-3

Here is a press release telling the public that drugs are the answer to osteoporosis. And a new drug is just around the corner. The article does mention that taking daily calcium and vitamin D-3 supplements is required with the drugs. However, if you read carefully, you will see that they never say how much greater increase in bone mineral density is produced by taking these costly drugs (with major side effects) over just taking calcium and vitamin D-3.

An infrequent but significant side effect associated with zoledronic acid in the clinical trial was an increased incidence of atrial fibrillation, an irregular heart rhythm.

Most oral osteoporosis medications fall under the general classification of bisphosphonates and include well-known brands like Fosamax, Boniva and Actonel. Side effects of using bisphosphonates include inflammation of the esophagus, esophageal erosion, difficulty swallowing, and bond death appearing initially in the jaw.

Read details on osteoporosis drugs, their side effects and the need to take calcium and vitamin D.

Wednesday, August 08, 2007

Why Are Insurance Costs and the Federal Deficit So High?

Why Are Insurance Costs and the Federal Deficit So High? Because all these costs seem to be acceptable. And everyone incures them. Wouldn't it be better to take a few supplements, support your health, and avoid these conditions and costs?

In the U.S., a quality-adjusted life year (QALY) falling between $50,000 and $100,000 is commonly considered a good value.

Comparative cost-effectiveness for selected interventions by Quality-Adjusted Life Year (QALY): • Mammography screening for breast cancer: $10,000 - $25,000/QALY** • Colon cancer screening: $10,000 - $25,000/QALY** • Osteoporosis screening: $10,000 - $25,000/QALY** • Hypertension medication: $10,000 - $60,000/QALY** • Cholesterol management: $10,000-$50,000/QALY** • Dialysis in end-stage renal disease: $50,000 - $100,000/QALY** • Aspirin for all eligible patients with coronary disease: $11,000/QALY* • Heart failure outpatient management program: $20,000/QALY* • Pneumococcal vaccination: $10,000 - $23,000/QALY* • Lifestyle training for diabetes: $54,000*

Read details of this quality-adjusted life year study.

Tuesday, August 07, 2007

Omega-3 greater anti-inflammatory potential than Omega-6

Researchers found a relative increase in omega-3 from fish oil or krill oil lowered the amount of prostanoids from omega-6 rich vegetable oil.

Smith wrote: "Dietary fish oil containing omega-3 highly unsaturated fatty acids has cardioprotective and anti-inflammatory effects.

This study adds further weight for other potential uses for omega-3. Studies have also shown the fatty acid has the ability to protect against the development of retinopathy, and ease symptoms associated with Alzheimer's disease.

View details of this omega-3 omega-6 anti-inflammatory study

Saturday, August 04, 2007

CoenzymeQ10 Boosts Endothelial Function

Supplementation with coenzyme Q10 (CoQ10) may boost naturally occurring antioxidant enzymes and endothelial function in patients with coronary artery disease (CAD), researchers have found.

Tiano stated the coenzyme Q10 also boosted endothelial function. She said: "The data from our group highlighted that CoQ10 greatly attenuates the endothelial dysfunction in patients affected by ischemic heart disease." The improvements were particularly significant in patients with low initial endothelium-bound ecSOD, who were more prone to oxidative stress, the study found.

Read details on this coenzyme Q10 endothelial funciton study.

Friday, August 03, 2007

Low Intake Of Omega-3 Poses More Risk Than Risk of Contaminants

Despite recommendations from the American Heart Association that fish should be consumed at least two times per week, only 17 percent of those surveyed reported eating fish that often. Only 24 percent said they ate fish a couple of times a month. By comparison, in the United States annual per capita consumption of poultry is 86 pounds, beef is 66 pounds, and fish consumption is a mere 16 pounds,

“We’re starting to realize in Indiana that the risk of not getting enough fish—and their benefits such as omega-3 fatty acids—is greater than any risks that fish may pose,” he said. “Many physicians are not well versed in the true risks. They’re telling their pregnant patients to simply not eat fish and that’s just very bad advice.”

In lieu of eating fish, Omega-3 supplements from fish oil and Neptune Krill Oil provide a healthy, contaminant-free source of DHA and EPA.

View details of this omega-3 contaminant risk article.

Wednesday, August 01, 2007

Diabetes Drugs Increase Risk of Heart Failure

A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers at Wake Forest University School of Medicine and colleagues.

Based on a review of research studies and case reports involving more than 78,000 patients, the authors concluded that the risk of heart failure may be up to 100 percent higher in patients taking thiazolinediones (which includes Avandia® and Actos®). These drugs are known to enhance insulin sensitivity.

USDA studies show cinnamon promotes glucose metabolism and supports healthy cholesterol levels in individuals with type 2 diabetes.

View details of this diabetes drug heart failure risk study.